TILMOVET 40 G/KG PREMIX FOR MEDICATED FEEDING STUFF FOR PIGS AND RABBITS
Land: Irland
Sprog: engelsk
Kilde: HPRA (Health Products Regulatory Authority)
Produktets egenskaber
(SPC)
21-11-2014
Nogle dokumenter til dette produkt er ikke tilgængelige i øjeblikket, du kan sende en anmodning til vores kundeservice, og vi vil underrette dig, så snart vi er i stand til at få dem.
Send anmodning.
Send anmodning.
Aktiv bestanddel:
TILMICOSIN
Tilgængelig fra:
Huvepharma NV
ATC-kode:
QJ01FA91
INN (International Name):
TILMICOSIN
Dosering:
40
Lægemiddelform:
Premix for Med.Feedstuffs
Recept type:
POM
Terapeutisk gruppe:
Porcine, Rabbits
Terapeutisk område:
Tilmicosin
Terapeutiske indikationer:
Antibacterial
Autorisation status:
Authorised
Autorisation dato:
2009-02-13
Produktets egenskaber
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Tilmovet 40 g/kg Premix for medicated feeding stuff for pigs and rabbits
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Active substance: 40 g tilmicosin per kg
Excipients:
For the full list of excipients, see section 6.1
3 PHARMACEUTICAL FORM
Premix for medicated feeding stuff
A yellowish tan to reddish tan free-flowing granular material.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Pigs (weaned piglets and fattening pigs) and rabbits.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Pigs:
Prevention and treatment of respiratory disease caused by _Actinobacillus pleuropneumoniae, Mycoplasma_
_hyopneumoniae, Pasteurella multocida _and other organisms sensitive to tilmicosin.
Rabbits:
Prevention and treatment of respiratory disease caused by _Pasteurella multocida _and _Bordetella bronchiseptica_,
susceptible to tilmicosin.
4.3 CONTRAINDICATIONS
Horses or other _Equidae_, must not be allowed access to feeds containing tilmicosin. Horses fed with tilmicosin
medicated feeds may present signs of toxicity with lethargy, anorexia, reduction of feed consumption, loose stools,
colic, distension of the abdomen and death.
Do not use in case of hypersensitivity to tilmicosin or to any of the excipients.
Do not use in animals hypersensitive to tilmicosin and when there is resistance to tilmicosin or cross resistance to other
macrolides like tylosin, erythromycin or lincomycin.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
With regard to the management of respiratory disease outbreaks, it should be noted that acutely ill animals are likely to
be inappetant and therefore require parenteral treatment.
HEALTH PRODUCTS REGULATORY AUTHORITY
________________________________________________________________________________________________________________
Læs hele dokumentet
